Form 4: 89bio CFO Ryan Martins Reports Stock Transaction
SEC Form 4 Filing
Ryan Martins, CFO of 89bio, Inc., reports a transaction involving common stock to cover tax obligations.
Summary
- On February 17, 2025, Ryan Martins, the Chief Financial Officer of 89bio, Inc., reported a transaction involving the company's common stock.
- The transaction involved the disposition of 780 shares of common stock at a price of $10.57.
- These shares were withheld to cover the estimated tax withholding obligation related to the vesting of restricted stock units.
- Following the transaction, Martins beneficially owns 269,674 shares of 89bio, Inc. common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, which is neutral in sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a standard practice of covering tax obligations related to stock-based compensation.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard practice for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/17/2025 | Date of the stock transaction. |
| 02/19/2025 | Date of signature for the Form 4 filing. |
Keywords
89bio, Ryan Martins, ETNB, CFO, stock transaction, Form 4, tax withholding, restricted stock units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.